CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Caris Life Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$30.71+0.15 (+0.49%)
Close on Oct 19, 2026
- Market cap
- $8.69B
- P/E (TTM)
- –
- Dividend yield
- –
Caris Life Sciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Market Cap | $8.68B | $1.14B |
| Enterprise Value | $8.97B | $1.35B |
| PS Ratio | 8.77 | 1.63 |
| PB Ratio | 14.67 | 3.03 |
| P/TBV Ratio | 15.16 | 4.99 |
| P/FCF Ratio | 70.01 | 20.54 |
| P/OCF Ratio | 51.49 | 15.44 |
Enterprise value
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| EV / Sales | 9.06 | 1.78 |
| EV / EBITDA | 51.54 | 14.40 |
| EV / EBIT | 58.52 | 19.04 |
| EV / FCF | 72.36 | 23.16 |
Income (trailing twelve months)
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Revenue | $989.61M | $561.90M |
| Operating Income | $153.26M | -$1.81M |
| Pretax Income | $105.02M | -$572.42K |
| Net Income | $105.14M | -$1.16M |
| EBITDA | $174.02M | -$20.72K |
Margins
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Operating Margin | 15.5% | -4.45% |
| Pretax Margin | 10.6% | 1.54% |
| Profit Margin | 10.6% | -2.91% |
| EBITDA Margin | 17.6% | 2.41% |
| FCF Margin | 12.5% | 3.13% |
Returns
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | 20.1% | 1.84% |
| Return on Assets (ROA) | 9.62% | -3.06% |
| Return on Invested Capital (ROIC) | 31.0% | 2.11% |
| Return on Capital Employed (ROCE) | 14.8% | -0.57% |
Growth
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 85.4% | 6.92% |
Balance sheet
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $102.20M | $48.71M |
| Total Debt | $393.15M | $140.00M |
| Net Cash (Debt) | -$290.95M | $205.49K |
| Net Cash Per Share | -$1.03 | $0.01 |
| Equity (Book Value) | $591.73M | $235.16M |
| Book Value Per Share | $2.09 | $3.48 |
| Tangible Book Value | $572.39M | $703.69K |
| Working Capital | $866.39M | $30.48M |
Financial position
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Current Ratio | 5.53 | 1.40 |
| Quick Ratio | 1.14 | 1.02 |
| Debt / Equity | 0.66 | 0.66 |
| Debt / EBITDA | 2.26 | 2.61 |
| Debt / FCF | 3.17 | 4.59 |
| Net Debt / EBITDA | 1.67 | 2.15 |
| Interest Coverage | 3.27 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Operating Cash Flow | $168.56M | $3.10M |
| Capital Expenditures | -$44.60M | -$18.62M |
| Free Cash Flow | $123.96M | $23.73M |
| FCF Per Share | $0.44 | $0.37 |
Efficiency
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Asset Turnover | 0.91 | 0.87 |
| Revenue Per Employee | $536.08K | $228.48K |
| Profits Per Employee | $56.95K | -$8.65K |
| Employee Count | 1,846 | 913 |
Dividends and yields
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Earnings Yield | 1.21% | -1.25% |
| FCF Yield | 1.43% | 1.74% |
| Buyback Yield | 0.25% | 0.32% |
| Shareholder Yield | 0.25% | 0.65% |
Shares
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Shares Outstanding | 282,595,000 | 58,282,400 |
| Shares Change (YoY) | 567.0% | 2.68% |
| Shares Change (QoQ) | -0.02% | 0.32% |
| Float | 101,438,000 | 33,780,100 |
| Shares Held by Insiders | 64.1% | 16.4% |
| Shares Held by Institutions | 54.5% | 85.9% |
Taxes
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Income Tax | -$111.00K | $697.00K |
| Effective Tax Rate | -0.11% | 23.1% |
Scores
| Measure | Caris Life Sciences | Industry median |
|---|---|---|
| Altman Z-Score | 7.32 | 1.96 |
| Piotroski F-Score | 6 | 5 |
Calculated by StockData from Caris Life Sciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.